On July 8, US President Trump delivered remarks at a cabinet meeting, covering tariffs and international affairs. On tariffs, he announced that imported pharmaceuticals and related products may face a maximum 200% tariff in the future, with a 1–1.5-year adjustment period for relevant enterprises. He also considered a 50% surtax on imported copper, which pushed US copper futures prices up over 10% to a record high. Citing a study, he claimed tariffs do not affect inflation but instead drive US prosperity, criticized Federal Reserve Chair Powell for overworrying about non-existent inflation, called for his resignation, and advocated for rate cuts.

Trump’s tariff policies could impact China’s instrument and equipment exports: higher export costs and reduced competitiveness; increased market uncertainty and operational risks; potential supply chain disruptions, with US-dependent enterprises possibly facing overcapacity.

Countermeasures for overseas expansion include: promoting high-end, innovative products to boost added value; diversifying markets to tap emerging ones; optimizing supply chains to reduce risks; and strengthening policy communication and industry collaboration to secure support and enhance resilience.